NDC 0409-0002-01 - Lidocaine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-0002
- Requested NDC
- 0409-0002-01
- Package NDCs from labels
- 0409-0002-01, 0409-0002-05, 0409-0002-10
- Manufacturer
- Hospira, Inc. | Pfizer Healthcare India Private Limited
- Effective date
- 2026-10-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LIDOCAINE - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-10-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, NATRUM MURIATICUM, SARSAPARILLA, SILICEA, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corp | 9883c502-9782-451e-9eec-c54d7b054f31 | 2017-01-31 | Warnings | 451W47IQ8X |
| CVS Pain Relieving First Aid Antiseptic | LIDOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE | CVS Pharmacy | 454b1773-eda8-5610-e054-00144ff88e88 | 2017-01-04 | Warnings | V13007Z41A |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM ACIDUM, CARBONEUM, CETRARIA ISLANDICA, FOLLICULINUM, FUCUS VESICULOSUS, FUMARICUM ACIDUM, HEPAR SUIS, KALI CARBONICUM, KREOSOTUM, NATRUM MURIATICUM, PARAFFINUM, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PIX LIQUIDA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PULSATILLA (VULGARIS), RADIUM BROMATUM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM OFFICINALE, TABACUM, TEREBINTHINA, THYROIDINUM (BOVINE), TRITICUM REPENS, ZINCUM OXYDATUM | Energetix Corp | 6b0d1628-b20d-426e-9c84-5cceadca3f45 | 2016-11-11 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2a96096d-43cc-49b7-af53-b53c17f41001 | 2014-07-25 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.